#MRNA #Moderna Today is up 14%. Last week, Moderna was added to a watchlist as a “sheep,” and it started showing strength right at the beginning of this week. Figure 2 shows Moderna’s future upside targets. Moderna is a pioneer—under its lead, healthcare stocks and biotech ETFs in Hong Kong, A-shares, and the U.S. market are all moving.
